<DOC>
	<DOCNO>NCT01157260</DOCNO>
	<brief_summary>Indoxyl sulfate ( IS ) uremic toxin accelerate progression chronic kidney disease ( CKD ) . AST-120 ( KremezinÂ® ; Kureha Corporation , Tokyo , Japan ) remove indole , precursor IS , intestine , reduces accumulation IS . This drug show retard deterioration renal function CKD patient reduce level IS . IS reported promote aortic calcification stimulate proliferation vascular smooth muscle cell ( VSMC ) . IS also inhibit endothelial proliferation wound repair . With background , investigator perform study whether AST-120 improve endothelial dysfunction CKD patient .</brief_summary>
	<brief_title>The Effects AST-120 Endothelial Dysfunction Patients With Chronic Kidney Disease</brief_title>
	<detailed_description>The purpose study examine whether Kremezin , Indoxyl sulfate lower agent improve endothelial dysfunction stage 3,4 chronic kidney disease patient</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Patients Chronic kidney disease ( Stage3 Stage4 ) Patients able willing understand , sign date inform consent document , authorize access protect health information Acute gastric duodenal ulcer Severe constipation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Indoxyl sulfate</keyword>
	<keyword>AST-120</keyword>
</DOC>